admin

Parkinsonism Drugs: Levodopa, Dopamine Agonists, MAO-B and COMT Inhibitors

Educational pharmacology review updated 10 November 2026. This information does not replace a patient-specific clinical evaluation or current local prescribing guidance. Overview Parkinsonism describes bradykinesia with tremor, rigidity or other features; idiopathic Parkinson disease must be distinguished from drug-induced and atypical syndromes. Medicines primarily improve motor symptoms but do not yet reliably stop neurodegeneration. Treatment…

Read Full News

Opioid Analgesics: Receptor Pharmacology, Safer Prescribing and Overdose Prevention

Educational pharmacology review updated 10 November 2026. This information does not replace a patient-specific clinical evaluation or current local prescribing guidance. Overview Opioids are analgesics for selected moderate-to-severe acute pain, cancer-related pain and palliative care, and for carefully selected chronic pain cases when benefits outweigh harms. For many common subacute and chronic pain conditions, nonopioid…

Read Full News

Mood Stabilizers: Lithium, Valproate, Lamotrigine and Bipolar Disorder Safety

Educational pharmacology review updated 10 November 2026. This information does not replace a patient-specific clinical evaluation or current local prescribing guidance. Overview Mood-stabilizing medicines prevent or manage manic, depressive and recurrent episodes in bipolar disorder, but their efficacy differs by episode polarity. Lithium remains a major maintenance option, while certain antipsychotics and anticonvulsants have phase-specific…

Read Full News

Antidepressants: SSRIs, SNRIs, TCAs, MAOIs, Clinical Use and Tapering

Educational pharmacology review updated 10 November 2026. This information does not replace a patient-specific clinical evaluation or current local prescribing guidance. Introduction Antidepressants are used for major depressive disorder and selected anxiety, obsessive-compulsive, pain and other conditions. Choice should incorporate symptom severity, patient preference, prior response, comorbidity, interacting medicines, pregnancy considerations and access to evidence-based…

Read Full News

Antipsychotic Drugs: Receptor Pharmacology, Schizophrenia Treatment and Clozapine Safety

Educational pharmacology review updated 10 November 2026. This information does not replace a patient-specific clinical evaluation or current local prescribing guidance. Overview Antipsychotics reduce psychotic symptoms in schizophrenia and are also used for specific bipolar disorder and other indications. Choice requires balancing symptom control with movement disorders, metabolic and cardiovascular risks, prior response and patient…

Read Full News

Antiseizure Medications: Mechanisms, Epilepsy Syndromes, Pregnancy and Monitoring

Medical education review updated 10 November 2026. Information is educational; treatment requires individualized clinical assessment and locally approved products. Overview Antiseizure medications (ASMs) reduce seizure recurrence through modulation of neuronal excitability or synaptic transmission. A drug that treats focal seizures may worsen some generalized epilepsies, so selection begins with seizure type, epilepsy syndrome, age, comorbidities,…

Read Full News

Barbiturates: GABA-A Pharmacology, Clinical Uses and Overdose Risks

Medical education review updated 10 November 2026. Information is educational; treatment requires individualized clinical assessment and locally approved products. Overview Barbiturates are sedative-hypnotic agents that potentiate inhibitory GABA neurotransmission. Clinical use has declined because of a narrow therapeutic index, respiratory suppression, enzyme induction and dependence. Phenobarbital remains useful for selected epilepsy indications and medically supervised…

Read Full News

Benzodiazepines: GABA-A Mechanism, Clinical Indications, Dependence and Tapering

Medical education review updated 10 November 2026. Information is educational; treatment requires individualized clinical assessment and locally approved products. Overview Benzodiazepines are positive allosteric modulators at GABA-A receptors with anxiolytic, anticonvulsant, sedative, muscle-relaxant and amnestic properties. They can be valuable for acute indications, but routine prolonged use for anxiety or insomnia raises risks of tolerance,…

Read Full News

Sedative-Hypnotics: Insomnia Pharmacology, CBT-I and Medication Safety

Medical education review updated 10 November 2026. Information is educational; treatment requires individualized clinical assessment and locally approved products. Overview Sedative-hypnotic drugs decrease wakefulness or promote sleep, but chronic insomnia should first be evaluated for medical, psychiatric, circadian and sleep-related breathing contributors. Cognitive behavioral therapy for insomnia (CBT-I) is recommended as first-line management. Medication selection,…

Read Full News

Myasthenia Gravis Drugs: Pyridostigmine, Immunotherapy and New Targeted Treatments

Medical education review updated 10 November 2026. Information is educational; treatment requires individualized clinical assessment and locally approved products. Overview Myasthenia gravis (MG) is an autoimmune disorder of neuromuscular transmission, most commonly involving acetylcholine receptor (AChR) or muscle-specific kinase (MuSK) antibodies. Weakness worsens with repeated activity and improves with rest, but respiratory or bulbar deterioration…

Read Full News